Mykhailo Mudryk Handed Four-Year Ban by FA for Anti-Doping Violation as CAS Appeal Continues

The English Football Association has imposed a four-year ban on Chelsea winger Mykhailo Mudryk following a doping case that has kept the 25-year-old out of professional football since November 2024. The ruling, announced on April 29, 2026, represents the maximum punishment available under FA Anti-Doping Regulations and concludes an 18-month disciplinary process — though it remains subject to challenge.

Mudryk was first issued a provisional suspension in December 2024 before being formally charged in June 2025. According to the FA’s official findings, the Ukrainian international breached Regulations 3 and 4 of the FA’s Anti-Doping Regulations — covering the presence and use of a prohibited substance — after returning a positive test for meldonium during a routine urine test. The substance, a cardiovascular medication, is banned under anti-doping rules due to its capacity to artificially enhance respiratory function and endurance. The FA’s findings indicate the exposure allegedly occurred while Mudryk was on international duty with Ukraine in October 2024.

Mudryk has consistently denied any intentional wrongdoing. He described the failed test as a “complete shock” and has stated publicly that he had “never knowingly used any banned substances.” His legal representatives at Morgan Sports Law filed a formal appeal with the Court of Arbitration for Sport (CAS) on February 25, 2026, with both sides currently exchanging written submissions ahead of a scheduled hearing. The Switzerland-based tribunal has yet to set a final verdict date.

Should CAS uphold the FA’s ruling without amendment, Mudryk would be barred from professional football until late 2028 — effectively stripping him of what would be the peak years of his career. In the interim, the forward has been maintaining fitness by training with a private coach and hired goalkeepers at non-league club Uxbridge FC, having been banned from Chelsea’s Cobham training facility.

The personal cost of the suspension has already been considerable. Mudryk, who signed for Chelsea in January 2023 in a deal worth a potential £89 million on an eight-and-a-half-year contract, was unable to participate in his club’s 2024/2025 UEFA Conference League title win. He travelled alone to Wrocław to watch his teammates defeat Real Betis in the final — a poignant detail that underscored the extent of his isolation from the squad.

Meldonium has featured prominently in high-profile doping cases in recent years. The drug was added to the World Anti-Doping Agency’s prohibited list in January 2016, triggering a wave of positive tests across multiple sports, most notably involving Russian and Eastern European athletes. Its presence in a sample does not automatically confirm deliberate use, a distinction that has played a central role in several successful appeals before CAS.

Transfer market implications also hang over the case. If the ban is confirmed, Chelsea — who committed to one of the most expensive winger contracts in Premier League history — face a significant financial and sporting loss, with Mudryk having made limited impact on the pitch before his suspension. The club has not issued a public statement regarding the FA’s ruling.

As reported by transfer journalist Fabrizio Romano, the four-year term represents the maximum sanction possible if ultimately confirmed. The CAS process is ongoing, and no hearing date has been publicly disclosed.